Featured Interview: CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY)

CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY), returns to Stock Day to talk about plans to eventually move up to the NASDAQ, revolutionizing cancer treatment, and approaching revenues by 2020.